BIONTECH SE - AMERICAN DEPOSITARY SHARES

Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study

01 4 2021 06:45:00 提供 Nasdaq GlobeNewswire

Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents

31 3 2021 06:45:00 提供 Nasdaq GlobeNewswire

BioNTech Announces Full Year 2020 Financial Results and Corporate Update

30 3 2021 06:30:00 提供 Nasdaq GlobeNewswire

BioNTech provides Update on Vaccine Production Status at Marburg Manufacturing Site

26 3 2021 09:45:00 提供 Nasdaq GlobeNewswire

EMA Approves New Storage Option for Pfizer-BioNTech Vaccine, Easing Distribution and Storage of Doses Across European Union

26 3 2021 09:20:00 提供 Nasdaq GlobeNewswire

BioNTech to Report Full Year Financial Results for 2020 and Provide Corporate Update on the Fourth Quarter on March 30, 2021

23 3 2021 07:00:00 提供 Nasdaq GlobeNewswire

Real-World Evidence Confirms High Effectiveness of Pfizer-BioNTech COVID-19 Vaccine and Profound Public Health Impact of Vaccination One Year After Pandemic Declared

11 3 2021 06:45:00 提供 Nasdaq GlobeNewswire

Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants

25 2 2021 06:45:00 提供 Nasdaq GlobeNewswire

Pfizer and BioNTech Submit COVID-19 Vaccine Stability Data at Standard Freezer Temperature to the U.S. FDA

19 2 2021 07:07:06 提供 Nasdaq GlobeNewswire

Pfizer and BioNTech Commence Global Clinical Trial to Evaluate COVID-19 Vaccine in Pregnant Women

18 2 2021 13:30:00 提供 Nasdaq GlobeNewswire